Literature DB >> 30244688

Interventions for hearing and vision impairment to improve outcomes for people with dementia: a scoping review.

Piers Dawes1, Lucas Wolski2, Ines Himmelsbach2, Jemma Regan3, Iracema Leroi3.   

Abstract

ABSTRACTBackground:Age-related hearing and vision problems are common among people with dementia and are associated with poorer function, reduced quality of life and increased caregiver burden. Addressing sensory impairments may offer an opportunity to improve various aspects of life for people with dementia.
METHODS: Electronic databases were searched using key terms dementia, hearing impairment, vision impairment, intervention, and management. Database searches were supplemented by hand searching bibliographies of papers and via consultation with a network of health professional experts. Studies were eligible for inclusion if they included adults aged over 50 with dementia with adult-onset hearing or vision impairment who had received a hearing or vision intervention in relation to cognitive function, rate of decline, psychiatric symptoms, hearing/vision-related disability, quality of life, and/or caregiver burden outcomes. A range of study designs were included. Results were summarized descriptively according to level of evidence and effect sizes calculated where possible. Risk of bias was assessed using Downs and Black's (1998) checklist. The development of the intervention was summarized according to the CReDECI2 scheme. PROSPERO review registration number 2016:CRD42016039737.
RESULTS: Twelve papers describing hearing interventions and five papers describing vision interventions were included. Most were of low to moderate quality. One high quality randomized controlled trial of a hearing aid intervention was identified. Hearing interventions included provision of hearing aids, assistive listening devices, communication strategies, hearing aid trouble shooting, and cochlear implantation. Vision interventions included prism lenses, rehabilitation training, and cataract surgery. There was no consistent evidence for the positive impact of hearing/vision interventions on cognitive function, rate of cognitive decline, quality of life, or caregiver burden.
CONCLUSION: Sensory interventions may promote better outcomes, but there is a need for properly powered, controlled trials of hearing and vision interventions on outcomes relevant to people living with dementia.

Entities:  

Keywords:  dementia; hearing impairment; intervention; management; non-pharmacological treatment; presbycusis; vision impairment

Mesh:

Year:  2018        PMID: 30244688     DOI: 10.1017/S1041610218000728

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  16 in total

Review 1.  [Dementia: relevant aspects for otorhinolaryngologists].

Authors:  R Dodel; C Völter
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

2.  Prevalence and correlates of vision impairment and its association with cognitive impairment among older adults in India: a cross-sectional study.

Authors:  T Muhammad; Drishti Drishti; Shobhit Srivastava
Journal:  BMJ Open       Date:  2022-05-06       Impact factor: 3.006

3.  Self-reported dual sensory impairment, dementia, and functional limitations in Medicare beneficiaries.

Authors:  Lama Assi; Joshua R Ehrlich; Yunshu Zhou; Alison Huang; Judith Kasper; Frank R Lin; Michael M McKee; Nicholas S Reed; Bonnielin K Swenor; Jennifer A Deal
Journal:  J Am Geriatr Soc       Date:  2021-09-03       Impact factor: 7.538

Review 4.  Hearing Impairment and Cognition in an Aging World.

Authors:  Danielle S Powell; Esther S Oh; Frank R Lin; Jennifer A Deal
Journal:  J Assoc Res Otolaryngol       Date:  2021-05-18

5.  Improving hearing and vision in dementia: protocol for a field trial of a new intervention.

Authors:  Jemma Regan; Piers Dawes; Annie Pye; Christopher J Armitage; Mark Hann; Ines Himmelsbach; David Reeves; Zoe Simkin; Fan Yang; Iracema Leroi
Journal:  BMJ Open       Date:  2017-11-28       Impact factor: 2.692

6.  Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.

Authors:  Jemma Regan; Eric Frison; Fidéline Collin; Piers Dawes; Mark Hann; Ines Himmelsbach; Emma Hooper; David Reeves; Zoe Simkin; Chryssoula Thodi; Fan Yang; Iracema Leroi
Journal:  Trials       Date:  2019-01-25       Impact factor: 2.279

7.  Assessing and managing concurrent hearing, vision and cognitive impairments in older people: an international perspective from healthcare professionals.

Authors:  Iracema Leroi; Ines Himmelsbach; Lucas Wolski; Jenna Littlejohn; Francine Jury; Angela Parker; Anna Pavlina Charalambous; Piers Dawes; Fofi Constantinidou; Chryssoula Thodi
Journal:  Age Ageing       Date:  2019-07-01       Impact factor: 10.668

8.  A randomised controlled trial of hearing and vision support in dementia: Protocol for a process evaluation in the SENSE-Cog trial.

Authors:  Iracema Leroi; Christopher J Armitage; Fidéline Collin; Eric Frison; Mark Hann; Emma Hooper; David Reeves; Zoe Simkin; Lucas Wolski
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

9.  The need for improved cognitive, hearing and vision assessments for older people with cognitive impairment: a qualitative study.

Authors:  Lucas Wolski; Iracema Leroi; Jemma Regan; Piers Dawes; Anna Pavlina Charalambous; Chryssoula Thodi; Juliana Prokopiou; Roxane Villeneuve; Catherine Helmer; Abebaw Mengistu Yohannes; Ines Himmelsbach
Journal:  BMC Geriatr       Date:  2019-12-03       Impact factor: 3.921

10.  Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial.

Authors:  Iracema Leroi; Zoe Simkin; Emma Hooper; Lucas Wolski; Harvey Abrams; Christopher J Armitage; Elizabeth Camacho; Anna Pavlina Charalambous; Fideline Collin; Fofi Constantinidou; Piers Dawes; Rachel Elliott; Sue Falkingham; Eric Frison; Mark Hann; Catherine Helmer; Ines Himmelsbach; Hannah Hussain; Sarah Marié; Susana Montecelo; Chryssoula Thodi; Wai Kent Yeung
Journal:  Int J Geriatr Psychiatry       Date:  2019-12-03       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.